Rivastigmine Tartrate CAS: 129101-54-8 Raw Powder

Rivastigmine Tartrate CAS: 129101-54-8 Raw Powder China Steroid Raws/ Sarms/ Peptides sell on line. If you want to know more details, please contact Jason on: Email: jason168@yccreate.com WhatsApp:+8618042849221 Keywords: Rivastigmine Tartrate, CAS: 129101-54-8 1. Product Introduction Product...

Product Details


Rivastigmine Tartrate CAS: 129101-54-8 Raw Powder


China Steroid Raws/ Sarms/ Peptides sell on line. If you want to know more details, please contact Jason on: Email: jason168@yccreate.com  WhatsApp:+8618042849221


Keywords: Rivastigmine Tartrate, CAS: 129101-54-8


1. Product Introduction

Product Name: Rivastigmine Tartrate

Alias: Rivastigmine-d6 tartarate

CAS: 129101-54-8

MF: C18H28N2O8

MW: 400.4235

Purity: 99%

MP: 123-125°C

BP: 316.2°C at 760 mmHg

FP: 145°C

Grade: Pharmaceutical Grade

Appearance: White Powder

Rivastigmine tartrate

2. Product description:

Rivastigmine Tartrate is a parasympathomimetic or cholinergic agent for the treatment of mild to moderate dementia of the Alzheimer's type and dementia due to Parkinson's disease. The drug can be administered orally or via a transdermal patch; the latter form reduces the prevalence of side effects, which typically include nausea and vomiting.

3. Rivastigmine Tartrate COA:

AppearanceA white to off-white hygroscopic crystalline powder
IdentificationShould conform
SolubilityShould conform
Specefic Rotation+10°~+14°(in 5mg/ml of water)
Heavy MetalsNMT0.002%
Limit of Free PhosphateNMT0.1%
Limit of SodiumNMT0.2%
Limit of chlorideNMT0.2%
Microbial Limits TestShould conform
Related substancesShould conform
Residual Solventsshould conform


4. Rivastigmine Tartrate Benefits

Rivastigmine Tartrate is rivastigmine Alzheimer's disease drugs, rivastigmine is physostigmine derivative by Novartis for the first time successfully developed the trade name Exelon (exelon), a molecule with there carbamate structure, is a kind of amino acid of selective cerebral cholinesterase inhibitor, can also inhibit the acetylcholinesterase and butyrylcholinesterase, cholinergic neurons by delaying the release of acetylcholine degradation and energy promoting cholinergic nerve conduction, can improve cognitive function disorders mediated by cholinergic, thereby improving the cognitive function of Alzheimer's disease patients.

Rivastigmine Tartrate plasma protein binding is weak, easily through the blood-brain barrier, which has a high degree of brain selectivity. It not only selectively acts on the most easily affected cerebral cortex and hippocampus, but also preferentially inhibits the dominant subtype of AChE in the brain, resulting in a reduction in the efficacy of peripheral cholinergic side effects. Rivastigmine in vivo half-life is short and long duration of action. Unlike tacrine, this product in the hippocampus and cortex of G1 enzyme inhibitory effect is stronger. Clinic for the treatment of mild to moderate Alzheimer-type dementia, or Alzheimer's disease can be suspected Alzheimer's disease clinically.

5. Related Products:

Adrafinils63547-13-7Beta nicotinamide mononucleotide1094-61-7
Nicotinamide ribose1341-23-7Aniracetam72432-10-1
Phenylpiracetam77472-70-9Piracetam hydrazide59776-89-5
NSI-1891270138-40-3NSI-189 phosphate1270138-41-4
Citicoline Sodium33818-15-44-Aminobutyric acid56-12-2
Unifiram272786-64-8Amfonelic acid15180-02-6


6. Order Process:


Hot Tags: rivastigmine tartrate cas: 129101-54-8 raw powder, China, manufacturers, suppliers, factory, wholesale


You Might Also Like